Clinical Trial Update: Effects of XOMA 052 on Insulin Production in Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the effect of XOMA 052 on insulin production in Type 1 diabetes has completed, sponsored by the University of Zurich.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• XOMA 052

Snippet

Sponsor: University of Zurich | Conditions: Diabetes Mellitus Type 1 | Phase 2 | Status: COMPLETED